StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. MRTX has been the subject of a number of other reports. SVB Leerink reiterated a market perform rating and issued a $58.00 price […]
Fiera Capital Corp Acquires 346,803 Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts have also recently commented on MRTX. Piper Sandler cut shares of Mirati Therapeutics from an overweight rating to a neutral rating and […]
Mirati Therapeutics (NASDAQ:MRTX) Now Covered by Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 845,566 shares were traded during trading, a decline of 36% from the previous session’s volume of 1,312,155 shares.The stock last traded at $58.69 and had previously closed at $58.80. Wall Street Analysts Forecast Growth A number of analysts […]